{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:50Z","timestamp":1786985450630,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"YAEL foundation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.bpg.2018.06.003","type":"journal-article","created":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T00:40:05Z","timestamp":1528936805000},"page":"55-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Variant syndromes of primary biliary cholangitis"],"prefix":"10.1016","volume":"34-35","author":[{"given":"Lisa","family":"Schulz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcial","family":"Sebode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren A.","family":"Weidemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8823-3129","authenticated-orcid":false,"given":"Ansgar W.","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2018.06.003_bib1","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bpg.2011.09.009","article-title":"Pathogenesis of autoimmune hepatitis","volume":"25","author":"Liberal","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2018.06.003_bib2","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","author":"Carey","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2018.06.003_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/00365529409103625","article-title":"Etiology and pathogenesis in primary sclerosing cholangitis","volume":"204","author":"Boberg","year":"1994","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.bpg.2018.06.003_bib4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","article-title":"Frequency and nature of the variant syndromes of autoimmune liver disease","volume":"28","author":"Czaja","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2018.06.003_bib5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2018.06.003_bib6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000444472","article-title":"Variant syndromes of autoimmune liver diseases: classification, diagnosis and management","volume":"34","author":"Weiler-Normann","year":"2016","journal-title":"Dig Dis"},{"key":"10.1016\/j.bpg.2018.06.003_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/jhep.2002.30699","article-title":"Fine specificity of autoantibodies to soluble liver antigen and liver\/pancreas","volume":"35","author":"Herkel","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2018.06.003_bib8","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","author":"European Association for the Study of the Liver","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2018.06.003_bib9","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.510290409","article-title":"Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals","volume":"29","author":"Lohse","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2018.06.003_bib10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1053\/jhep.2001.27562","article-title":"Autoimmune hepatitis with incidental histologic features of bile duct injury","volume":"34","author":"Czaja","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2018.06.003_bib11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.22380","article-title":"Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis","volume":"48","author":"O\u2019Brien","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2018.06.003_bib12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/MEG.0000000000000870","article-title":"Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis","volume":"29","author":"Muratori","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2018.06.003_bib13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouill\u00e8res","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2018.06.003_bib14","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.cgh.2010.03.004","article-title":"Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome","volume":"8","author":"Kuiper","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2018.06.003_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the Liver","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2018.06.003_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/jhep.2002.30902","article-title":"Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid","volume":"35","author":"Joshi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2018.06.003_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5387\/fms.52.71","article-title":"Clinicolaboratory characteristics of Japanese patients with primary biliary cirrhosis-autoimmune hepatitis overlap","volume":"52","author":"Saito","year":"2006","journal-title":"Fukushima J Med Sci"},{"key":"10.1016\/j.bpg.2018.06.003_bib18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1440-1746.2009.06018.x","article-title":"Overlap of primary biliary cirrhosis and autoimmune hepatitis: characteristics, therapy, and long term outcomes","volume":"25","author":"Yokokawa","year":"2010","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2018.06.003_bib19","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/MEG.0000000000000075","article-title":"Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis","volume":"26","author":"Efe","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2018.06.003_bib20","first-page":"660","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: simplified criteria may be effective in the diagnosis in Chinese patients","volume":"15","author":"Liu","year":"2014","journal-title":"J\u00a0Dig Dis"},{"key":"10.1016\/j.bpg.2018.06.003_bib21","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2018.06.003_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2018.06.003_bib23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/0891693021000064272","article-title":"The hepatitic\/cholestatic \u201coverlap\u201d syndrome: an Italian experience","volume":"35","author":"Muratori","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.bpg.2018.06.003_bib24","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1572-0241.2002.05703.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system","volume":"97","author":"Talwalkar","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2018.06.003_bib25","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes","volume":"102","author":"Silveira","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2018.06.003_bib26","article-title":"Assessment of 479 patients with autoimmune liver diseases according to the IAIHG scoring system for autoimmune hepatitis does not support the contention of overlap syndromes as separate diagnostic entities","volume":"50","author":"Boberg","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2018.06.003_bib27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ajg.2009.616","article-title":"Autoimmune hepatitis\u2013PBC overlap syndrome: a simplified scoring system may assist in the diagnosis","volume":"105","author":"Neuhauser","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2018.06.003_bib28","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1007\/s10620-016-4213-3","article-title":"Natural history of patients presenting with autoimmune hepatitis and coincident nonalcoholic fatty liver disease","volume":"61","author":"De Luca-Johnson","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2018.06.003_bib29","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1007\/s10620-016-4258-3","article-title":"Nonalcoholic fatty liver disease in patients with autoimmune hepatitis: further reason for teeth GNASHing?","volume":"61","author":"Weiler-Normann","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2018.06.003_bib30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group","volume":"41","author":"Vergani","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2018.06.003_bib31","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1055\/s-2001-12906","article-title":"Nachweis von SLA\/LP-Autoantik\u00f6rpern bei Patienten mit prim\u00e4r bili\u00e4rer Zirrhose als Marker f\u00fcr eine sekund\u00e4re autoimmune Hepatitis (Overlapsyndrom)","volume":"126","author":"Kanzler","year":"2001","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.bpg.2018.06.003_bib32","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/ajg.2009.126","article-title":"The serological profile of the autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome","volume":"104","author":"Muratori","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2018.06.003_bib33","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.26666","article-title":"Antismooth muscle and antiactin antibodies are indirect markers of histological and biochemical activity of autoimmune hepatitis","volume":"59","author":"Couto","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2018.06.003_bib34","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/hep.27983","article-title":"Prediction of short- and long-term outcome in patients with autoimmune hepatitis","volume":"62","author":"Kirstein","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2018.06.003_bib35","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.510290444","article-title":"Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression","volume":"29","author":"Degott","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2018.06.003_bib36","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2018.06.003_bib37","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1440-1827.2009.02405.x","article-title":"Liver biopsy in primary biliary cirrhosis: clinicopathological data and stage","volume":"59","author":"Drebber","year":"2009","journal-title":"Pathol Int"},{"key":"10.1016\/j.bpg.2018.06.003_bib38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2018.06.003_bib39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1440-1827.2009.02500.x","article-title":"Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: interobserver agreement","volume":"60","author":"Nakanuma","year":"2010","journal-title":"Pathol Int"},{"key":"10.1016\/j.bpg.2018.06.003_bib40","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/liv.12620","article-title":"Primary biliary cirrhosis: proposal for a new simple histological scoring system","volume":"35","author":"Wendum","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.bpg.2018.06.003_bib41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1309\/AJCPDZR4OHDQNG3L","article-title":"Revisiting the topic of histochemically detectable copper in various liver diseases with special focus on venous outflow impairment","volume":"139","author":"Mounajjed","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bpg.2018.06.003_bib42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2559.1989.tb03060.x","article-title":"A\u00a0cytokeratin immunohistochemical study of cholestatic liver disease: evidence that hepatocytes can express \u201cbile duct-type\u201d cytokeratins","volume":"15","author":"Van Eyken","year":"1989","journal-title":"Histopathology"},{"key":"10.1016\/j.bpg.2018.06.003_bib43","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1309\/VHHD-HTRU-N8J2-5X7R","article-title":"Portal tract eosinophils and hepatocyte cytokeratin 7 immunoreactivity helps distinguish early-stage, mildly active primary biliary cirrhosis and autoimmune hepatitis","volume":"116","author":"Goldstein","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bpg.2018.06.003_bib44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hep.21229","article-title":"Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis","volume":"44","author":"Poupon","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2018.06.003_bib45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1586\/17474124.1.2.329","article-title":"Overlap syndromes with autoimmune hepatitis in chronic cholestatic liver diseases","volume":"1","author":"Silveira","year":"2007","journal-title":"Expet Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2018.06.003_bib46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12016-015-8516-5","article-title":"The natural history and prognosis of primary biliary cirrhosis with clinical features of autoimmune hepatitis","volume":"50","author":"Yang","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"issue":"Suppl 2","key":"10.1016\/j.bpg.2018.06.003_bib47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000440831","article-title":"Overlap syndromes","volume":"33","author":"Chazouill\u00e8res","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.bpg.2018.06.003_bib48","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jhep.2005.10.017","article-title":"Long term outcome and response to therapy of primary biliary cirrhosis\u2014autoimmune hepatitis overlap syndrome","volume":"44","author":"Chazouill\u00e8res","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2018.06.003_bib49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0399-8320(07)89323-7","article-title":"Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease","volume":"31","author":"Heurgu\u00e9","year":"2007","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.bpg.2018.06.003_bib50","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cgh.2013.09.021","article-title":"Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis","volume":"12","author":"Ozaslan","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2018.06.003_bib51","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A\u00a0placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpg.2018.06.003_bib52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"Hirschfield","year":"2017","journal-title":"J\u00a0Hepatol"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691818300271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691818300271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,10]],"date-time":"2018-11-10T08:13:58Z","timestamp":1541837638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691818300271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":52,"alternative-id":["S1521691818300271"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2018.06.003","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variant syndromes of primary biliary cholangitis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2018.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}